A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01100827

Enrollment

Unknown

Registered

2010-04-09

Start date

2013-02-28

Completion date

2015-02-28

Last updated

2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Keywords

EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC, The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.

Brief summary

To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC. To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.

Interventions

OTHEREGFR mutation status in patients

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to No maximum

Inclusion criteria

Nil

Exclusion criteria

Nil

Countries

Singapore

Contacts

Primary ContactRoss Andrew Soo, MBBS

ross_soo@nuhs.edu.sg65 6772 4624

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026